1900 Wealth Management LLC Sells 68 Shares of Intuitive Surgical, Inc. $ISRG

1900 Wealth Management LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 14.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 407 shares of the medical equipment provider’s stock after selling 68 shares during the quarter. 1900 Wealth Management LLC’s holdings in Intuitive Surgical were worth $221,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in ISRG. Chilton Capital Management LLC raised its holdings in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the last quarter. Elite Financial Inc. bought a new position in Intuitive Surgical in the 1st quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical in the 1st quarter valued at approximately $30,000. TD Capital Management LLC raised its holdings in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 45 shares during the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical in the 1st quarter valued at approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. The trade was a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 in the last quarter. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Up 1.1%

Shares of ISRG stock opened at $443.01 on Friday. The company has a market cap of $158.81 billion, a price-to-earnings ratio of 61.79, a price-to-earnings-growth ratio of 4.59 and a beta of 1.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a 50 day moving average of $464.42 and a 200-day moving average of $500.22.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company’s quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.78 EPS. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on ISRG. Wall Street Zen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Friday, September 26th. Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a report on Wednesday, July 23rd. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Piper Sandler restated an “overweight” rating and set a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Truist Financial raised their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $594.19.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.